to : 16 December 2018
Meet TransCure bioServices’team at ESMO Immuno-Oncology Congres!
Working on Immuno-Oncology is one of the main priorities of TransCure bioServices. Being up-to-date about this field is essential for keeping high standard services.
If you are interested about meeting our team in December from 13th to 16th, please request a meeting by writing to our Director Business Development, Romain GRET:
What it ESMO Immuno-Oncology Congress?
The ESMO Immuno-Oncology Congress helps to increase the overall understanding of the potential of immunotherapy and its implications for clinical practice, today and in the future.
The Congress keeps oncologists up-to-date in this rapidly evolving field and is the ideal platform for all interested stakeholders. From the basics of immunotherapies to the latest research results; from understanding different treatment options to management of toxicities and interpretation of new data, the Congress builds the European community of immuno-oncology stakeholders
Who are we?
TransCure bioService is a pre-clinical CRO dedicated to the evaluation of treatments for HIV, immuno-oncology, and inflammations diseases. Our team elaborates unique Research & Development (R&D) and fee-for-service platforms, called the Full Human Immune System Mouse Models (hu-mouse models). Therefore, customers access these full services (protocol design, data collection and analysis) in our BSL-2 and BSL-3 animal and laboratory facilities on a very attractive fee-for-service basis.